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Background: Recently, postnatal stem cells from dental papilla with neural crest origin have been considered as
one of potent stem cell sources in regenerative medicine regarding their multi-differentiation capacity and relatively
easy access. However, almost human oral tissues have been reported to be infected by mycoplasma which gives
rise to oral cavity in teeth, and mycoplasma contamination of ex-vivo cultured stem cells from such dental tissues
and its effect on stem cell culture has received little attention.
Results: In this study, mycoplama contamination was evaluated with stem cells from apical papilla which were
isolated from human third molar and premolars from various aged patients undergoing orthodontic therapy. The
ex-vivo expanded stem cells from apical papilla were found to express stem cell markers such as Stro-1, CD44,
nestin and CD133, but mycoplama contamination was detected in almost all cell cultures of the tested 20 samples,
which was confirmed by mycoplasma-specific gene expression and fluorescence staining. Such contaminated
mycoplasma could be successfully eliminated using elimination kit, and proliferation test showed decreased
proliferation activity in mycoplasma-contaminated cells. After elimination of contaminated mycoplasma, stem
cells from apical papilla showed osteogenic and neural lineage differentiation under certain culture conditions.
Conclusion: Our study proposes that the evaluation of mycoplasma contamination and elimination process
might be required in the use of stem cells from apical papilla for their potent applications to tissue engineering and
regenerative medicine.
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Tooth morphogenesis is known to be initiated from the
cellular interactions between ectoderm-derived oral epi-
thelial cells and neural crest-derived mesenchymes [1,2],
and stem cell researches to generate osteoblasts and
neurons have been done extensively using stem cells
from dental tissues with such neural crest-derived ecto-
mesenchyme origin [3-5]. To dates, various postnatal
stem cells have been successfully isolated from the col-
lected dental tissues such as dental pulp, periodontal* Correspondence: yshwang@khu.ac.kr
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unless otherwise stated.ligament and dental papilla via non-invasive procure-
ment process [3,6,7]. During tooth development, dentin
and pulp tissue are known to be developed from dental
papilla, which dental papilla is evident to have a pool of
stem cells with high regeneration ability [8,9], and the
majority of stem cell within dental papilla has been re-
ported to be of neural crest-derived ectomesenchyme
origin [10]. From these developmental origin, relatively
easy accessibility of stem cell source from discarded
tooth and possible autologous implantation via cryo-
preservation in dental stem cell bank, dental papilla has
been suggested as potent stem cell source in regenera-
tive medicine. For instance, in the field of tissue engin-
eering and regenerative medicine, bioengineered toothis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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cells from molar tooth germ tissue [11], in vivo bone for-
mation could be generated via transplantation of tissue
engineered bone tissue formed by cryopreserved dental
stem cells [12,13], and the generation of functional neu-
rons were reported to be from dental stem cell under
neural inductive cues [14].
However, in spite of high applicability of stem cells from
dental tissues in tissue engineering and regenerative medi-
cine, mycoplasma contamination of the primary cultured
stem cells from dental tissues where is easily infected by
oral bacteria has been overlooked, and the evaluation and
removal of infected mycoplasma in dental stem cells need
to be considered, regarding biological safety in dental stem
cells applications to regenerative medicine. It was reported
that almost human oral tissue was frequently found to
be infected small microorganism such as mycoplasma
[15], and many kinds of bacteria give rise to oral cavity
in teeth, and mycoplasma, the smallest and simplest self-
replicating organisms, is known as one of major bacteria
found in oral cavity [16]. Postnatal stem cells from in-
fected dental tissues are evident to be infected by myco-
plasma, and such mycoplama infection in dental tissues
might influence dental tissue-derived stem cell’s behavior
including cell proliferation. It is well known that myco-
plasma infection influenced cell proliferation, chromo-
somal aberration in cells and induced immunological
reactions [17,18]. Hence, in this study, postnatal stem
cells were primarily isolated and cultured from apical
papilla of the third molar and premolar teeth from vari-
ous aged patients undergoing orthodontic therapy, and
mycoplasma contamination was evaluated for each iso-
lated stem cells from apical papilla (hSCAPs) of human
teeth. The cell proliferation capacity was also tested with
mycoplasma-infected and -eliminated hSCAPs, and then
2D and 3D osteogenic and neural differentiation capacities
of mycoplasma-eliminated hSCAPs were evaluated for the
potent application to bone and neural tissue engineering
(Figure 1 I).
Method
Primary culture of Stem Cells from Apical Papilla (hSCAPs)
of the human premolar and third molar teeth
Briefly, human dental papilla tissue was procured from
discarded 6 ~ 24 aged donor’s premolar and third molar
teeth with informed consent of patients undergoing rou-
tine extractions at the Dental Clinic of School of Dentistry
in Kyung Hee University, under approved guidelines set
by the Kyung Hee University and School of Dentisty
Human Subjects Research Committees (IRB# KHUSD
0908–01). The extracted teeth were directly stored in
alpha-MEM (Lonza) containing 1% penicillin/streptomycin
(P/S, Lonza), and the teeth were used to procure pa-
pilla tissue within 2 hours after teeth extraction. Dentalapical papilla tissues were extracted from the premolar
and third molar teeth, and were minced with a scalpel.
The fragmented papilla tissues were washed with phos-
phate buffered saline (PBS: Gibco) three times, and the
minced tissues were allowed to attach on T25 tissue culture
flasks in basic culture medium consisting of alpha-MEM,
10% fetal bovine serum (FBS, lonza), and 1% penicillin/
streptomycin. Cultures were fed every 2 days and passaged
by treatment with 0.25% trypsin/EDTA. Cell Cultures
were grown at 37°C in a humidified atmosphere contain-
ing 5% CO2.
Morphological and immunocytochemical characterization
of hSCAPs
1 × 104 cell/cm2 of hSCAPs were seeded on 24 well plate
(Corning) and cultured for 2 days. The attached cells
were fixed with 3.7% formaldehyde (Sigma) for 20 mins
at room temperature, and fixed cells were washed with
PBS. The cells were permeabilized with 0.2% Triton
X-100 (Sigma) treatment for 20 mins, and, after brief
washing with PBS, were treated with 4% bovine serum
albumin (BSA: Sigma) to block non-specific binding of
antibodies at 4°C for overnight. After blocking, the cells
were incubated with primary antibodies such as 1:200-
diluted mouse-anti-nestin (Abcam) antibody, 1:200-diluted
mouse-anti-Stro-1 (Abcam) antibody, and 1:200-diluted
mouse-anti-CD44 (Abcam), and 1:200-diluted mouse-
anti-CD133 (Abcam) at 4°C for overnight. After reaction
with primary antibodies, the cells were washed gently with
PBS three times, and then incubated with secondary anti-
bodies such as 1:2000-diluted alexa 488 (goat anti-mouse
IgG, Invitrogen), 1:2000-diluted alexa 596 (goat anti-
mouse IgG, Invitrogen) for 1 hr at room temperature
under dark condition. Finally, after brief washing with PBS
three times, the cells were counter-stained with DAPI,
and mounted. The stained cells were observed under an
inverted fluorescence microscope (Olympus, IX-72).
Detection of mycoplasma contamination
Mycoplasma contamination of primary cultured hSCAPs
was evaluated by mycoplasma specific staining method
and polymerase chain reaction (PCR) method.
For mycoplasma staining, cell suspension was prepared
by trypsin-EDTA treatment for 5 minutes and subsequent
neutralization with culture media. Mycoplama staining
was processed with prepared hSCAPs suspension and
Mycoplasma Detection Kit according to manufacturer’s
instruction. Briefly explaining, 95 μl of cell suspension
(1 × 105 cell/ml) was mixed with 5 μl of MycoFluor™
Mycoplasma Detection Kit (Invitrogen) in micro-centrifuge
tube, and the mixed cell suspension was incubated for 30
mins at 37°C in a 5% CO2 incubator. After incubation, the
stained sample was observed under an inverted fluores-


























Figure 1 Schematic illustration of the applications of hSCAPs to bone and neural tissue engineering and characterization of primary
cultured hSCAPs. I. Schematic illustration of bone and neural differentiation of mycoplasma eliminated hSCAPs for bone and neural tissue
engineering. II. Morphology and immunocytochemical images of the primary cultured stem cells from apical papilla (hSCAPs). A. Cell outgrowth
from apical papilla tissue fragment. B. Expanded hSCAPs. C. Stro-1(green) and nuclear staining (DAPI; blue). D. CD44 (red) and nuclear staining
(DAPI; blue). E. SEM image of the expanded hSCAPs in the presence of NGF, FGF2 and LIF. F. CD44 (green) and nuclear staining (DAPI; blue) of
the expanded hSCAPs in the presence of NGF, FGF2 and LIF. G. Nestin (green) and nuclear staining (DAPI; blue) of the expanded hSCAPs in the
presence of NGF, FGF2 and LIF. H. CD133 (red) and nuclear staining (DAPI; blue) the expanded hSCAPs in the presence of NGF, FGF2 and LIF.
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PCR was processed with BioMycoX Mycoplasma PCR
Detection Kit (Cells-safe) according to manufacturer’s
instruction. Briefly, after 24 hrs of culture, 1 ml of cul-
ture media was collected, and centrifuged at 3000 rpm
for 5 mins. After centrifuge, supernatant was transferred to
microcentrifuge tube, and was centrifuged at 13,000 rpm
for 10 mins. After centrifuge, mycoplasma pellet was col-
lected, and suspended with 100 μl of dH2O, and then
boiled at 98°C for 10 mins. 50 μl of supernatant was trans-
ferred into new PCR tubes. For PCR reaction, supernatant
was mixed with 5 μl PCR template, 2 μl primer mix (Cells-
safe), 2 μl dH2O and 10 μl 2X PCR premix (Cells-safe).
PCR reactions were performed as following conditions:
pre-denaturation process at 95°C for 5 mins with 1 cycle,
denaturation process at 94°C for 30 secs with 35 cycles, an-
nealing process at 55°C for 30 secs with 35 cycles, and ex-
tension process at 72°C for 30 secs with 35 cycles. Finally,all PCR products were loaded on 0.7% argarose gel con-
taining ethidium bromide at concentration of 0.5 μg/ml.
Mycoplasma elimination
Mycoplasma elimination of contaminated hSCAPs was
processed using BioMycoX® Mycoplasma Elimination
Kit (Cells-safe). After detection of mycoplasma contam-
ination, 5 × 106 of the mycoplasma-infected hSCAPs was
seeded on a T75 flask and cultured in culture media at
37°C in a 5% CO2 incubator. When the confluence of
cells reached at 70 ~ 80%, the cells were trypsinized, neu-
tralized with culture media, and then centrifuged at
1500 rpm for 5 mins. After centrifuged, cell pellet was col-
lected, and then suspend with culture media containing
5% FBS. 2.5 × 106 cells/ml was mixed with 200 μl of
BioMycoX® Reagent 1, and total volume was adjusted
to 10 ml with culture media. The cell suspension was
transferred to a T75 flask, and incubated for 3 days
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After 3 days of incubation, attached cells were trypsinized,
and then centrifuged at 1500 rpm for 5 mins. After centri-
fuge, cell pellet was collected and suspended with culture
media containing 10% FBS. Cell suspension was mixed
with 200 μl of BioMycoX® Reagent 2, and total volume
was adjusted to 10 ml with culture media. The cells were
incubated for 2 days without media change at 37°C in a
5% CO2 incubator, which treatment with BioMycoX®
Reagent 2 was repeated two times.
Proliferation assay of mycoplasma-infected and -eliminated
hSCAPs
Mycoplasma-infected hSCAPs and mycoplasma-eliminated
hSCAPs were seeded at cell density of 1 × 104 cells on 96
well plate and incubated for 24 hrs at 37°C in a 5% CO2
incubator. The BrdU incorporation based cell proliferation
assay was processed with BrdU assay kit (Merck) accord-
ing to manufacturer’s instruction. Briefly, after 24 hrs of
incubation, 1:2000 diluted BrdU working solution was
added into hSCAPs culture media, and the cells were in-
cubated for 3 hrs. The BrdU incorporated cells were
treated with 200 μl of fixative/denaturing solution for
30 mins at room temperature. After reaction, fixative/
denaturing solution was aspirated, and the cells were
incubated with 1:100 diluted mouse anti-BrdU in dilution
buffer solution for 1 hr at room temperature. After wash-
ing with washing buffer three times, the cells were reacted
with 100 μl goat anti-mouse IgG HRO conjugate for 30
mins at room temperature, and then washed with wash-
ing buffer three times. Finally, the cells were reacted
with 100 μl of substrate solution in the dark at room
temperature for 15 mins, and subsequently 100 μl of
stop solution was added to each well. The content of
incoporated BrdU in cellular DNA was measured using a
spectrophotometric plate reader at dual wavelengths of
450–540 nm (or 450–595).
2D and 3D osteogenic differentiation of
mycoplasma-eliminated hSCAPs
Prior to osteogenic differentiation, primary cultured hSCAPs
were expanded in α-MEM supplemented with 15% FBS,
and 1% penicillin/streptomycin. For osteogenic differenti-
ation, hSCAPs was seeded on culture plated at cell density
of 1 × 105/cm2 and cultured in osteogenic medium; α-
MEM supplemented with 15% FBS, and 1% penicillin/
streptomycin containing 50 μg/ml ascorbic acid (Sigma)
in PBS, 1 μM dexamethasone (Sigma) in PBS and 10 mM
β-glycerophosphate (Sigma) in PBS. The cultures were
maintained at 37°C in a 5% CO2 humidified incubator and
fed every 2 days up to 20 days. After 20 days of osteogenic
culture, the differentiated cells were fixed with 3.7% for-
maldehyde for 1 min or 20 mins at room temperature,
and fixed cells were washed with PBS. The fixed cells werestained with phenotypic alkaline phosphatase (ALP) stain-
ing kit (Chemicon) and alizarin red-S (Sigma) staining so-
lution according to manufacturer’s instruction.
In addition, for 3D osteogenic differentiation, hSCAPs
were suspended in 1.1% (w/v) alginic acid (Sigma) and
0.1% (v/v) porcine gelatin (Sigma) solution (all dissolved
in PBS, pH 7.4), as described before [19]. Briefly, the
cell-gel solution was passed through a peristaltic pump
(EYELA) and dropped using a 25-gauge needle into ster-
ile alginate gelation solution composing of 100 mM
CaCl2 (Sigma), 10 mM HEPES (Sigma), and 0.01% (v/v)
Tween (Sigma) at pH 7.4 with stirring. Approximately
10,000 cells were encapsulated in each alginate hydrogel.
The hydrogels remained in gently stirred CaCl2 solution
for 6–10 mins and were then washed with PBS. The
hSCAPs containing hydrogels were transferred to in 10 ml
vessels of HARV bioreactors (Synthecon) and the vessels
was rotated at 25 rpm. Subsequently, 3D osteogenic differ-
entiation was induced using the same osteogenic medium
described above. The bioprocess is illustrated in Figure 2 II.
After 3D osteogenic differentiation, the sections of hydro-
gels were stained with alizarin red-S staining solution ac-
cording to manufacturer’s instruction.
2D and 3D neural differentiation of mycoplasma-
eliminated hSCAPs
Prior to neural differentiation, primary cultured hSCAPs
were expanded in culture medium consisting of DMEM/
F12 mixture (1:1, with glucose, L-glutamine, HEPES Buf-
fer, Lonza), 10% FBS, 20 ng/ml epithelial growth factor
(EGF, Peprotech), 10 ng/ml basic fibroblast growth factor
(FGF2, Peprotech), 1000 unit/ml LIF (Invitrogen) and 1%
penicillin/streptomycin. For neural differentiation, hSCAPs
was allowed to form neurospheres by plating non-adherent
culture dishes in the presence of 100 ng/ml FGF2 in cul-
ture medium consisting of DMEM/F12 mixture, 10%
FBS, 1000 unit/ml LIF (Invitrogen) and 1% penicillin/
streptomycin for 3 days at 37°C in a 5% CO2 humidified
incubator. The formed neurospheres were replated on
laminin (10 μg/ml, Invitrogen)-coated culture dishes and
were allowed to direct neural differentiation in neurobasal
medium (Gibco) supplemented with 2% B27 (Invitrogen),
1X insulin-transferrin-sodium-selenite (ITS, BD science),
1% penicillin/streptomycin, 30 ng/ml of NGF, 20 ng/ml
EGF and 10 ng/ml FGF2 for one week. Subsequently,
hSCAPs were maintained in neuroinduction medium con-
sisting of in neurobasal media (Gibco), 1% B27 supplement
(Invitrogen), 1% non-essential amino acid (Gibco), 1 X
ITS, 100 units/ml penicillin and 100 μg/ml streptomycin,
100 ng/ml GNDF (Peprotech) and 0.5 μM retinoic acid
(Sigma). All of the media were replaced twice a week.
In addition, for 3D neural differentiation, hSCAPs which
dissociated from neurospheres were mixed with matrigel
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Eliminated P16 Infected P16
Figure 2 Mycoplasma-specific PCR analysis and fluorescence staining for primary cultured hSCAPs and proliferation activity. I. PCR
analysis for 20 samples. II. fluorescence staining of mycoplasma in hSCAPs culture: arrow indicates positive staining of mycoplasma colony. III.
mycoplasma-specific fluorescence staining of hSCAPs from selected 4 samples before and after mycoplasma elimination process. IV. proliferation
assay for hSCAPs from selected 4 samples before and after mycoplasma elimination process.
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ges on syringe pump, and the solutions passed through
double jet nodule and dropped into sterile alginate gel-
ation solution composing of 100 mM CaCl2, 10 mM
HEPES, and 0.01% (v/v) Tween at pH 7.4 with mild stir-
ring. The hydrogels remained in gently stirred CaCl2 solu-
tion for 6–10 mins and were then washed with PBS. The
bioprocess is illustrated in Figure 2 IIIE. The hSCAPs/
matrigel were placed in inner side and alginate hydrogel
were formed to be outer layer enveloping cell/matrigel.
The 3D neural differentiation of hSCAPs containing
hydrogels was induced by the culture under same culture
condition described before. After 2D and 3D neural differ-
entiation, the cells were fixed with 3.7% formaldehyde for
20 mins at room temperature, and neural differentiation
was characterized by immunocytochemical staining with
primary antibodies such as Ca2+/calmodulin-dependent
protein kinases II (rabbit anti-human Cam kinase II,
Abcam) and βIII-tubulin (mouse anti-human βIII-tubulin,
Abcam).Result
Characterization of primary cultured Stem Cells from
Apical Papilla (hSCAPs)
Papilla tissues were procured from pre-molar and third
molar tooth of patients aged from 6 to 24 which infor-
mation of the used teeth is noticed in Table 1, and the
minced papilla tissues were placed to be adhered on cul-
ture flasks. The outgrowth of cells from papilla tissues
was detectable in one or two weeks of tissue attachment
(Figure 1 IIA). During the expansion of primary isolated
cells from apical papilla, two distinguished cell popula-
tions were detected under different culture conditions.
When the cells were expanded in α-MEM supplemented
with 10% FBS, most cells showed fibroblastic morphology,
and small population showing spherical shape was found
(Figure 1 IIB). Such spherical shaped cell population was
largely found during the expansion in the presence of
EGF, FGF2 and LIF (Figure 1 IIE). This morphological dif-
ference of cell populations showed different molecular ex-
pression, and their stem cell characteristic was evaluated
Table 1 Information of premolar and third molar teeth used in this study
Sample # Sex Age Teeth Sample # Sex Age Teeth
1 Male 6 Pre-molar 11 Male 19 Third-molar
2 Male 11 Pre-molar 12 Female 23 Third-molar
3 Male 6 Pre-molar 13 Female 24 Third-molar
4 Male 9 Pre-molar 14 Female 12 Pre-molar
5 Male 10 Pre-molar 15 Female 17 Third-molar
6 Male 12 Pre-molar 16 Female 12 Pre-molar
7 Male 11 Pre-molar 17 Female 13 Pre-molar
8 Male 14 Pre-molar 18 Female 11 Pre-molar
9 Male 10 Pre-molar 19 Female 6 Pre-molar
10 Male 14 Pre-molar 20 Female 7 Pre-molar
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As shown in Figure 1 IIC and D, most of fibroblastic cells
derived from papilla tissues showed strongly positive reac-
tions against anti-Stro-1and CD44, and, in contrast, spher-
ical shaped cells did not show positive expression of CD44
(Figure 1 IIF), but showed relatively stronger expressions
of nestin and CD133 (Figure 1 IIG and H).Mycoplasma detection and elimination of primary
cultured hSCAPs
Mycoplasma contamination of primary cultured hSCAPs
was evaluated by PCR analysis and by mycoplasma-specific
staining analysis. PCR analysis was done using BioMycoX
mycoplasma PCR detection kit which primers is designed
to react specifically with the highly conserved coding
region in the mycoplasma genome. All expanded hSCAPs
which derived from patients aged from 6 to 24 were
tested, and, as shown in Figure 2 I, gel running with
PCR products showed two bands in all tested samples:
one band with approximate size of 700 bp was an internal
DNA band to confirm the well PCR reaction, and the other
bands which positioned around 250–300 bp indicated
mycoplasma contamination. Even though sample number
11 showed relatively week band intensity in comparison
with other samples, PCR analysis showed most clear evi-
dence of mycoplasma contamination of all tested hSCAPs.
Accompanied with the analysis of mycoplasma con-
tamination in gene level, mycoplasma contamination was
also evaluated by mycoplasma-specific staining analysis
using MycoFluor™ mycoplasma detection kit. As shown in
Figure 2 II, four samples (patient number 4, 8, 15, and 16)
of hSCAPs were selected randomly for staining, and all
tested hSCAPs cultures showed positive staining of myco-
plasma colony in live cells. Relatively small sized blue
fluorescent spots indicate stained mycoplasma colonies
within cytosol of hSCAPs, and nucleus within dead cells
showed larger fluorescent spots. In addition, mycoplasma-
positive staining was frequently detectable around nucleus.After the detection of mycoplasma contamination via PCR
and mycoplasma-specific staining analysis, Mycoplasma was
eliminated from the contaminated hSCAPs using BioMycoX®
Mycoplasma Elimination Kit. After mycoplasma elimin-
ation of randomly selected hSCAPs sample, the presence of
mycoplasma was evaluated by mycoplasma-specific staining
PCR analysis. As shown in Figure 2 III, the mycoplasma-
eliminated hSCAPs culture did not show any bands at
approximate size of 250–300 bp in PCR analysis, which in-
dicates well elimination of contaminated mycoplasma.
Proliferation activity of mycoplasma-contaminated and
-eliminated hSCAPs
Four samples (patient number 4, 8, 15, and 16) were se-
lected randomly to evaluate the effect of mycoplasma
contamination on cell proliferation, and the proliferation ac-
tivity of mycoplasma-contaminated and -eliminated hSCAPs
was analyzed by BrdU incorporation assay. As shown in
Figure 2 IV, although the extent of differences in prolif-
eration activities between mycoplasma-contaminated
hSCAPs and mycoplasma-eliminated hSCAPs was varied
in the selected samples, mycoplasma-eliminated hSCAPs
showed generally much higher proliferation activities than
mycoplasma-contaminated hSCAPs throughout whole
culture period. Some hSCAPs showed two fold increase in
proliferation activity at 5 days of cultures after myco-
plasma elimination, which demonstrates the negative ef-
fect of mycoplasma contamination on cell proliferation
activity.
Osteogenic and neural differentiation of
mycoplasma-eliminated hSCAPs
With mycoplasma-eliminated hSCAPs, 2D and 3D osteo-
genic and neural differentiation were induced under cer-
tain osteogenic and neural differentiation conditions.
For 2D osteogenic differentiation of mycoplasma-
eliminated hSCAPs, ostegenic differentiation of hSCAPs
was induced in the presence of osteogenic supplements such
as ascorbic acid, dexamethasone and β-glycerophosphate,
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increase of phenotypic ALP expression during osteogenic
differentiation. After 20 days of osteogenic differentiation,
mineralized nodules were formed in osteogenic culture of
hSCAPs throughout whole culture area, which proved by
strong positive staining with alizarin red-S (Figure 3 ID, F
and G), and such mineralized nodules were found to have
high content of calcium and phosphate, which proved by
high fluorescence in alizarin red-S staining under fluores-
cent microscope (Figure 3 IE). In addition to 2D osteo-
genic differentiation of mycoplasma-eliminated hSCAPs,
3D osteogenic differentiation of hSCAPs were induced by














Figure 3 Osteogenic and neural differentiation of mycoplasma-elimin
hSCAPs: A, B and C. Phenotypic ALPase expression after 5, 10 and 15 days of o
nodules after 20 days of osteogenic culture under light microscope, E. alizarin
culture under fluorescence microscope, II. 3D Osteogenic differentiation of m
hydrogel encapsulating hSCAPs, D and E. alizarin red-S stained image of mine
culture under fluorescence microscope, III. 2D and 3D neural differentiation o
hSCAPs in 2D neural differentiation culture. C and D. βIII tubulin (red), Cam ki
of hSCAPs encapsulation of hSCAPs for 3D neural differentiation. F. tubular alg
tubular alginate hydrogel, H. microscopic images of hSCAPs in 3D neu
and nuclear staining (DAPI; blue) of differentiated hSCAPs in 3D neural d
staining (DAPI; blue) of differentiated hSCAPs in 3D neural differentiation cultuin a rotating HARV bioreactor (Figure 3 II). 3D highly
mineralized nodules formed by differentiated hSCAPs
within alginate hydrogel were found at 20 days of dy-
namic osteogenic culture (Figure 3 IID and E)
For 2D neural differentiation of mycoplasma-eliminated
hSCAPs, hSCAPs were allowed to form neurospheres in
the presence of FGF2 and FBS and then hSCAPs-derived
neurospheres were plated on laminin-coated culture, 2D
neural differentiation was induced by the neural inductive
culture in the presence of NGF, EGF, and FGF2 for one
week and by the subsequent neural maturation culture
in the presence of GDNF and retinoic acid. As shown in























ated hSCAPs. I. 2D Osteogenic differentiation of mycoplasma-eliminated
steogenic culture, D, F and G. Alizarin red-S stained image of mineralized
red-S stained image of mineralized nodules after 20 days of osteogenic
ycoplasma-eliminated hSCAPs: A. alginate hydrogel, B and C: alginate
ralized nodules within alginate hydrogel after 20 days of 3D osteogenic
f mycoplasma-eliminated hSCAPs: A and B. microscopic images of
nase II (green) and nuclear staining (DAPI; blue), E. Schematic illustration
inate hydrogel, G. live and dead image of encapsulated hSCAPs in
ral differentiation culture, I. βIII tubulin (red), Cam kinase II (green)
ifferentiation culture, J. βIII tubulin (green), Cam kinase II (red) and nuclear
re, Scale bars indicate 200 μm.
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neurite from differentiated hSCAPs was also detected
around the plated neurospheres. In addition, the differen-
tiated hSCAPs expressed βIII-tubulin along with the ex-
tended neurite and cell bodies and expressed cam kinase
II, indicating neural differentiation (Figure 3 IIIC and D).
In addition to 2D neural differentiation of mycoplasma-
eliminated hSCAPs, neurosphere-derived single cell sus-
pension was mixed with matrigel and encapsulated alginate
hydrogel using double jet nodule (Figure 3 IIIE), and 3D
neural differentiation was induced under the same culture
condition. As shown in Figure 3 IIIF and G, alginate
hydrogel well formed the outer layer encapsulating cells,
and encapsulated hSCAPs showed well viability within
hydrogel, and multipolar cells expressing neural markers
such as βIII-tubulin and cam kinase II were found within
hydrogel (Figure 3 IIIH-J).
Discussion
Recently, postnatal stem cells from dental tissues have
been received great attention in the field of tissue engin-
eering and regenerative medicine in terms of relatively
easy accessibility, multi-differentiation capacity and pos-
sible autologus implantation. Implantation studies showed
in vivo bone and neural tissue regeneration capacity of
implanted dental tissue-derived stem cell [13,14,20]. Re-
garding developmental origin, so called neural crest de-
rived ectomesenchyme, of stem cells to participate in tooth
morphogenesis, different lineage differentiation, mesen-
chymal differentiation and neuroectodermal differenti-
ation, might be derived from postnatal stem cells from
dental tissues under certain circumstance [1,2]. The resi-
dence of postnatal stem cells showing multi-differentiation
capacity have been identified within various dental tissues
such as dental pulp, periodontal ligament, and papilla tis-
sues [3,6,7], and, among these dental tissues, papilla tissue
which generally found in a developing tooth is known to
be a pool of stem cells [21]. In our study, different stem cell
populations could be generated by the culture under differ-
ent culture conditions during expansion of stem cells
from apical papilla (hSCAPs), and a stem cell population
showing fibroblastic spindle shape during the expansion
expressed mesenchymal markers such as Stro-1 and CD44
which consistent to the previous report to show the deriv-
ation of stem cells with mesenchymal characteristic from
dental papilla tissue [3], but, during hSCAPs expansion in
the presence of EGF, FGF2 and LIF, distinct cell popula-
tion with spherical shape appeared and expressed of
neural stem cell markers such as nestin and CD133 [22].
Both expressions of mesenchymal and neural stem cell
maker of papilla-derived stem cells might be related to their
stem cell characteristics which derived from neural crest-
derived ectomesenchyme in tooth developmental process
[9,23]. However, it might be necessary to investigate moreabout the characteristics of postnatal stem cells from dental
tissues to broaden their therapeutic applications.
In spite of potent usefulness of stem cells from dental
tissues in tissue engineering and regenerative medicine,
for clinical application and stem cell researches using
postnatal stem cells from dental tissues, bacterial con-
tamination should be considered in fact most teeth are
usually extracted due to oral disease such as oral cavity
which might be frequently related with bacterial infec-
tions. Especially, mycoplasma is one of most popular
microorganism frequently found in oral cavity [16], and
is the smallest prokaryote with below 1 μm in a diameter
which small size allows mycoplasma to pass through
conventional filters used to prohibit bacterial and fungal
contamination, and mycoplasma easily absorb into host
animal cells [15]. In that dental tissues can be frequently
exposed to bacterial infection, mycoplasma infection of
propagated dental tissue-derived cell cultures is probably
unavoidable. In our study, most premolar and third molar
teeth were extracted from patient for orthopedic surgery to
cure oral disease, and papilla tissues was procured from the
discarded teeth. After isolation, mycoplasma contamin-
ation was evaluated with primary cultured hSCAPs,
and most hSCAPs were found to be contaminated by
mycoplasma, which were proved by positive staining and
mycoplasma-specific DNA expression. To confirm the
possible cross-contamination from other cells in our la-
boratory, adipose-derived stem cell, human dermal fibro-
blasts and primary cultured periodontal ligament cells was
used to test mycoplasma contamination, but there was no
sign of mycoplasma contamination (data not shown). Such
mycoplasma contamination is known to affect many as-
pects of cell physiology such as cell proliferation, chromo-
somal aberration and also immunological reactions [17,18].
For example, the 50% of inhibition in cell proliferation was
reported by influencing nutrient consumption of cells dur-
ing cell culture [17]. In addition, upon in vivo implantation
of mycoplasma-contaminated cells, mycoplasma from in-
fected cells might affect host cells participating in im-
munological reactions such as macrophage activation and
inhibition of antigen presentation [18]. In our study, the
contaminated mycoplasma in hSCAPs were eliminated,
and it was found that mycoplasma contamination affected
cell proliferation activity of primary culture hSCAPs. Fi-
nally, the mycoplasma-eliminated hSCAPs showed multi-
differentiation capacity into osteogenic and neural lineage
cells under certain culture conditions, and also 3D osteo-
genic and neural differentiation could be successfully in-
duced using hydrogel encapsulation technique or dynamic
culture system for their application to tissue engineering.
Our study might suggest that the experimental process of
mycoplasma elimination may be required for primary cell
culture and for the application of primary cells to tissue
engineering and regenerative medicine, but its time-
Kim et al. Biomaterials Research  (2015) 19:6 Page 9 of 9consuming and expensive process, which takes approxi-
mately for 7–10 days, is still a problem to be overcome for
its practical application to conventional culture process.
Conclusion
Our study showed that dental papilla-derived stem cells
could be isolated from the discard human premolar and
third molar teeth after orthodontic therapy and that al-
most dental papilla-derived stem cell was shown to be
infected by mycoplasma, which mycoplasma infection
affected cell proliferation activity. Such infected myco-
plasma in dental papilla-derived stem cells could be
clearly eliminated using the mycoplasma elimination kit,
and mycoplasma-eliminated stem cells showed multi-
differentiation activity into osteogenic and neural lineage
differentiation. Based on scientific knowledge that infected
mycoplasma can affect cell proliferation activity, chromo-
somal aberration and immune response in cell culture and
implantation, mycoplasma detection and elimination process
should be considered as one of essential steps prior to
stem cell research and potent clinical application using
postnatal stem cells from dental tissues.
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